|
|
|
|
|
|
|
|
|
|
Note: this study is not specific to ovarian cancer but may be of interest for those deciding on Sorafenib:
"Muscle loss is a sorafenib adverse effect that may relate to asthenia, fatigue, and physical disability."
Friday, January 22, 2010
abstract: Association of Skeletal Muscle Wasting With Treatment With Sorafenib
Note: this study is not specific to ovarian cancer but may be of interest for those deciding on Sorafenib:
"Muscle loss is a sorafenib adverse effect that may relate to asthenia, fatigue, and physical disability."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.